EUVIMEDEUVIMED entdecken
Crossref

SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis

Xiang Song, Xinzhao Wang, Xiqi Chen, Zhiyong Yu, Yongkun Zhou

Journal of Proteomics · 2024

DOI: 10.1016/j.jprot.2023.105055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteomics, 2024. Verfasst von Xiang Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China; Breast Cancer Center, Shandong Ca…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Antineoplastic Agents, Ferroptosis. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin (DDP) is a commonly used chemotherapeutic agent for triple negative breast cancer (TNBC), but its efficacy can be limited by chemoresistance. This study aimed to explore the functional mechanism of SR-rich splicing factor 1 (SRSF1) in DDP chemosensitivity of TNBC cells. Levels of SRSF1, circular RNA septin 9 (circSEPT9), and GTP cyclohydrolase-1 (GCH1) in TNBC cells, DDP-resistant cells, and normal cells were determined. Cell viability, half-maximal inhibitory concentration (IC50) value, and proliferation were evaluated. Ferroptosis was determined by assay kits (ferric ion/ROS/MDA/GSH) and Western blot assay (SLC7A11/ACSL4). The genetic binding was analyzed by RNA immunoprecipitation and RNA pull-down assays. SRSF1, circSEPT9, and GCH1 were upregulated in TNBC cells. SRSF1 downregulation reduced IC50 to DDP of parent and drug-resistant TNBC cells and inhibited cell viability and proliferation, meanwhile, the downregulation reduced GSH/SLC7A11 levels while elevated ferric ion/ROS/MDA/ACSL4 levels, promoting ferroptosis. SRSF1 bound to and upregulated circSEPT9 and circSEPT9 blocked the ubiquitination of GCH1, thereby increasing GCH1 protein level. Overexpression of circSEPT9 and GCH1 attenuated the DDP chemosensitivity of TNBC cells by inhibiting ferroptosis. This study is the first to report the role of SRSF1 inhibitors combined with chemotherapy in TNBC, which provides a promising strategy for the treatment of TNBC. SIGNIFICANCE: Cisplatin (DDP) is a commonly used chemotherapeutic agent for triple negative breast cancer (TNBC), but its efficacy can be limited by chemoresistance. This study aimed to unravel the molecular mechanism of SR-rich splicing factor 1 (SRSF1) in DDP chemosensitivity of TNBC cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsAntineoplastic AgentsFerroptosisHumansCisplatinRNA, CircularGTP CyclohydrolaseReactive Oxygen SpeciesDrug Resistance, NeoplasmCell Line, TumorRNA Splicing FactorsCell ProliferationSerine-Arginine Splicing Factors

Stichwörter der Autor:innen

CisplatinFerroptosisSRSF1Triple negative breast cancercircSEPT9

Substanzen

CisplatinAntineoplastic AgentsRNA, CircularGTP CyclohydrolaseReactive Oxygen SpeciesRNA Splicing FactorsSRSF1 protein, humanSerine-Arginine Splicing Factors

Autor:innen und Institutionen

  • First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China; Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Sha…
  • Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China; REMEGEN, LTD, Yantai Economic & Technological Deve…
  • First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China; Department of General Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medici…

Zitieren

APA

Song, X., Wang, X., Chen, X., Yu, Z., & Zhou, Y. (2024). SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis. Journal of Proteomics. https://doi.org/10.1016/j.jprot.2023.105055

Vancouver

Song X, Wang X, Chen X, Yu Z, Zhou Y. SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis. Journal of Proteomics. 2024. doi:10.1016/j.jprot.2023.105055

BibTeX
@article{Song2024,
  author = {Song, Xiang and Wang, Xinzhao and Chen, Xiqi and Yu, Zhiyong and Zhou, Yongkun},
  title = {SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis},
  journal = {Journal of Proteomics},
  year = {2024},
  doi = {10.1016/j.jprot.2023.105055}
}
Kostenlos starten →